Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceutical Research|December 2, 2021
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics ExperimentsWataru Takemura, Sho Tashiro, Marina Hayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 31, 2012
Pharmacokinetics of ampicillin-sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgeryYuta Yokoyama, Kazuaki Matsumoto, Hiroyuki Yamamoto, et al.
The Keio Journal of Medicine|June 29, 2025
Analysis of the Stability of 0.04% Mitomycin C Ophthalmic Solution under Various Storage ConditionsYuma Nonomiya, Koki Yamaguchi, Yuta Yokoyama, et al.
Journal of Clinical Laboratory Analysis|July 12, 2022
Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detectionYuta Yokoyama, Eiji Nozawa, Miho Morita, et al.
Journal of Epidemiology|June 20, 2017
Online version of the self-administered food frequency questionnaire for the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT) protocol: Relative validity, usability, and comparison with a printed questionnaireErika Kato, Ribeka Takachi, Junko Ishihara, et al.
Frontiers in Oncology|November 25, 2021
Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective StudyToshiki Ogiwara, Hitoshi Kawazoe, Saeka Egami, et al.
Plos One|July 28, 2025
Identification of risk factors and development of a predictive model in patients using cefmetazole for international normalized ratio elevationTakaya Namiki, Yuta Yokoyama, Motonori Kimura, et al.
Biological & Pharmaceutical Bulletin|May 7, 2025
Efficacy of De-Escalation to Cefmetazole in Patients with Bacteremic Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coliTakaya Namiki, Yuta Yokoyama, Motonori Kimura, et al.
International Journal of Hematology|January 26, 2019
Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemiaMasatoshi Sakurai, Taku Kikuchi, Daiki Karigane, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 18, 2022
Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serumEmi Ishikawa, Yuta Yokoyama, Haruna Chishima, et al.
Pageof 6